{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:12:12Z","timestamp":1793653932856,"version":"4.5.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"national institute of diabetes and digestive and kidney diseases","doi-asserted-by":"publisher","award":["R01 DK120565"],"award-info":[{"award-number":["R01 DK120565"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"national institute of diabetes and digestive and kidney diseases","doi-asserted-by":"publisher","award":["R01 DK116750"],"award-info":[{"award-number":["R01 DK116750"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"national institute of diabetes and digestive and kidney diseases","doi-asserted-by":"publisher","award":["R01 DK106236"],"award-info":[{"award-number":["R01 DK106236"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"national institute of diabetes and digestive and kidney diseases","doi-asserted-by":"publisher","award":["R01 DK107437"],"award-info":[{"award-number":["R01 DK107437"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"national institute of diabetes and digestive and kidney diseases","doi-asserted-by":"publisher","award":["P30DK116074"],"award-info":[{"award-number":["P30DK116074"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"u.s. national library of medicine","doi-asserted-by":"publisher","award":["T15 LM 007033"],"award-info":[{"award-number":["T15 LM 007033"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["1T32AG047126-01"],"award-info":[{"award-number":["1T32AG047126-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["R01 AG066490"],"award-info":[{"award-number":["R01 AG066490"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"american diabetes association","doi-asserted-by":"publisher","award":["1-19-JDF-108"],"award-info":[{"award-number":["1-19-JDF-108"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"national institute of mental health","doi-asserted-by":"publisher","award":["R01 MH125244"],"award-info":[{"award-number":["R01 MH125244"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"national human genome research institute","doi-asserted-by":"publisher","award":["U01 HG009431"],"award-info":[{"award-number":["U01 HG009431"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"national heart, lung, and blood institute","doi-asserted-by":"publisher","award":["R01 HL142015"],"award-info":[{"award-number":["R01 HL142015"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Identification of causal genes for polygenic human diseases has been extremely challenging, and our understanding of how physiological and pharmacological stimuli modulate genetic risk at disease-associated loci is limited. Specifically, insulin resistance (IR), a common feature of cardiometabolic disease, including type 2 diabetes, obesity, and dyslipidemia, lacks well-powered genome-wide association studies (GWAS), and therefore, few associated loci and causal genes have been identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here, we perform and integrate linkage disequilibrium (LD)-adjusted colocalization analyses across nine cardiometabolic traits (fasting insulin, fasting glucose, insulin sensitivity, insulin sensitivity index, type 2 diabetes, triglycerides, high-density lipoprotein, body mass index, and waist-hip ratio) combined with expression and splicing quantitative trait loci (eQTLs and sQTLs) from five metabolically relevant human tissues (subcutaneous and visceral adipose, skeletal muscle, liver, and pancreas). To elucidate the upstream regulators and functional mechanisms for these genes, we integrate their transcriptional responses to 21 relevant physiological and pharmacological perturbations in human adipocytes, hepatocytes, and skeletal muscle cells and map their protein-protein interactions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identify 470 colocalized loci and prioritize 207 loci with a single colocalized gene. Patterns of shared colocalizations across traits and tissues highlight different potential roles for colocalized genes in cardiometabolic disease and distinguish several genes involved in pancreatic \u03b2-cell function from others with a more direct role in skeletal muscle, liver, and adipose tissues. At the loci with a single colocalized gene, 42 of these genes were regulated by insulin and 35 by glucose in perturbation experiments, including 17 regulated by both. Other metabolic perturbations regulated the expression of 30 more genes not regulated by glucose or insulin, pointing to other potential upstream regulators of candidate causal genes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our use of transcriptional responses under metabolic perturbations to contextualize genetic associations from our custom colocalization approach provides a list of likely causal genes and their upstream regulators in the context of IR-associated cardiometabolic risk.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13073-022-01036-8","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T15:03:01Z","timestamp":1647356581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Integration of genetic colocalizations with physiological and pharmacological perturbations identifies cardiometabolic disease genes"],"prefix":"10.1186","volume":"14","author":[{"given":"Michael J.","family":"Gloudemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunilda","family":"Balliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nachun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia M.","family":"Schnurr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Durrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Ingelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wabitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Quertermous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Carcamo-Orive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"1036_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00125-009-1620-4","volume":"53","author":"RK Simmons","year":"2010","unstructured":"Simmons RK, Alberti KGMM, Gale EAM, Colagiuri S, Tuomilehto J, Qiao Q, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO expert consultation. Diabetologia. 2010;53:600\u20135.","journal-title":"Diabetologia."},{"key":"1036_CR2","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120:1640\u20135.","journal-title":"Circulation."},{"key":"1036_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"G Reaven","year":"1988","unstructured":"Reaven G. Role of insulin resistance in human disease: Banting lecture 1988. Diabetes. 1988;37:1595\u2013607.","journal-title":"Diabetes."},{"key":"1036_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jama.2019.9161","volume":"322","author":"NS Shah","year":"2019","unstructured":"Shah NS, Lloyd-Jones DM, O\u2019Flaherty M, Capewell S, Kershaw KN, Carnethon M, et al. Trends in cardiometabolic mortality in the United States, 1999-2017. JAMA. 2019;322:780\u20132.","journal-title":"JAMA."},{"key":"1036_CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","volume":"70","author":"RS Khan","year":"2019","unstructured":"Khan RS, Bril F, Cusi K, Newsome PN. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology. 2019;70:711\u201324.","journal-title":"Hepatology."},{"key":"1036_CR6","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1210\/jcem.86.8.7763","volume":"86","author":"FS Facchini","year":"2001","unstructured":"Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001;86:3574\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1036_CR7","doi-asserted-by":"publisher","first-page":"e6613827","DOI":"10.1155\/2021\/6613827","volume":"2021","author":"M Maru\u0161i\u0107","year":"2021","unstructured":"Maru\u0161i\u0107 M, Pai\u0107 M, Knobloch M, Liberati Pr\u0161o A-M. NAFLD, insulin resistance, and diabetes mellitus type 2. Can J Gastroenterol Hepatol. 2021;2021:e6613827.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"1036_CR8","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50:1505\u201313.","journal-title":"Nat Genet"},{"key":"1036_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-020-2263-3","volume":"582","author":"CN Spracklen","year":"2020","unstructured":"Spracklen CN, Horikoshi M, Kim YJ, Lin K, Bragg F, Moon S, et al. Identification of type 2 diabetes loci in 433,540 east Asian individuals. Nature. 2020;582:240\u20135.","journal-title":"Nature."},{"key":"1036_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41588-018-0332-4","volume":"51","author":"K Suzuki","year":"2019","unstructured":"Suzuki K, Akiyama M, Ishigaki K, Kanai M, Hosoe J, Shojima N, et al. Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population. Nat Genet. 2019;51:379\u201386.","journal-title":"Nat Genet"},{"key":"1036_CR11","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/s41467-018-04951-w","volume":"9","author":"A Xue","year":"2018","unstructured":"Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9:2941.","journal-title":"Nat Commun"},{"key":"1036_CR12","doi-asserted-by":"publisher","unstructured":"Vujkovic M, Ramdas S, Lorenz KM, Guo X, Darlay R, Cordell HJ, He J, Gindin Y, Chung C, Meyers RP, Schneider CV. A trans-ancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation. medRxiv. 2021:2020\u201312. https:\/\/doi.org\/10.1101\/2020.12.26.20248491.","DOI":"10.1101\/2020.12.26.20248491"},{"key":"1036_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41588-018-0084-1","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan A, Wessel J, Willems SM, Zhao W, Robertson NR, Chu AY, et al. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat Genet. 2018;50:559\u201371.","journal-title":"Nat Genet"},{"key":"1036_CR14","doi-asserted-by":"crossref","unstructured":"Udler MS, Kim J, von Grotthuss M, Bon\u00e0s-Guarch S, Cole JB, Chiou J, et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLoS Med. 2018;15 [cited 2021 Mar 23]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6150463\/.","DOI":"10.1371\/journal.pmed.1002654"},{"key":"1036_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","volume":"27","author":"R Wagner","year":"2021","unstructured":"Wagner R, Heni M, Tab\u00e1k AG, Machann J, Schick F, Randrianarisoa E, et al. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat Med. 2021;27:49\u201357.","journal-title":"Nat Med"},{"key":"1036_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","volume":"7","author":"OP Zaharia","year":"2019","unstructured":"Zaharia OP, Strassburger K, Strom A, B\u00f6nhof GJ, Karusheva Y, Antoniou S, et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diab Endocrinol. 2019;7:684\u201394.","journal-title":"Lancet Diab Endocrinol"},{"key":"1036_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diab Endocrinol. 2018;6:361\u20139.","journal-title":"Lancet Diab Endocrinol"},{"key":"1036_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/3112","volume":"20","author":"D Lauro","year":"1998","unstructured":"Lauro D, Kido Y, Castle AL, Zarnowski M-J, Hayashi H, Ebina Y, et al. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat Genet. 1998;20:294\u20138.","journal-title":"Nat Genet"},{"key":"1036_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/MCO.0b013e32830349a1","volume":"11","author":"JRB Perry","year":"2008","unstructured":"Perry JRB, Frayling TM. New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care. 2008;11:371\u20137.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1036_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s00125-008-1025-9","volume":"51","author":"JC Florez","year":"2008","unstructured":"Florez JC. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia. 2008;51:1100\u201310.","journal-title":"Diabetologia."},{"key":"1036_CR21","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.2337\/db11-0415","volume":"60","author":"RJ Strawbridge","year":"2011","unstructured":"Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, Rybin D, et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes. 2011;60:2624\u201334.","journal-title":"Diabetes."},{"key":"1036_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cmet.2013.01.009","volume":"17","author":"R Singh","year":"2013","unstructured":"Singh R, De Aguiar RB, Naik S, Mani S, Ostadsharif K, Wencker D, et al. LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans. Cell Metab. 2013;17:197\u2013209.","journal-title":"Cell Metab"},{"key":"1036_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1101\/gad.235499.113","volume":"28","author":"J Zhang","year":"2014","unstructured":"Zhang J, McKenna LB, Bogue CW, Kaestner KH. The diabetes gene Hhex maintains \u03b4-cell differentiation and islet function. Genes Dev. 2014;28:829\u201334.","journal-title":"Genes Dev"},{"key":"1036_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cmet.2013.12.002","volume":"19","author":"T Gao","year":"2014","unstructured":"Gao T, McKenna B, Li C, Reichert M, Nguyen J, Singh T, et al. Pdx1 maintains \u03b2 cell identity and function by repressing an \u03b1 cell program. Cell Metab. 2014;19:259\u201371.","journal-title":"Cell Metab"},{"key":"1036_CR25","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1172\/JCI74692","volume":"125","author":"JW Knowles","year":"2015","unstructured":"Knowles JW, Xie W, Zhang Z, Chennamsetty I, Chennemsetty I, Assimes TL, et al. Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. J Clin Invest. 2015;125:1739\u201351.","journal-title":"J Clin Invest"},{"key":"1036_CR26","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.2337\/db16-0199","volume":"65","author":"GA Walford","year":"2016","unstructured":"Walford GA, Gustafsson S, Rybin D, Stan\u010d\u00e1kov\u00e1 A, Chen H, Liu C-T, et al. Genome-wide association study of the modified Stumvoll insulin sensitivity index identifies BCL2 and FAM19A2 as novel insulin sensitivity loci. Diabetes. 2016;65:3200\u201311.","journal-title":"Diabetes."},{"key":"1036_CR27","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ng.443","volume":"41","author":"J Rung","year":"2009","unstructured":"Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proen\u00e7a C, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009;41:1110\u20135.","journal-title":"Nat Genet"},{"key":"1036_CR28","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1301824","volume":"370","author":"AR Keramati","year":"2014","unstructured":"Keramati AR, Fathzadeh M, Go G-W, Singh R, Choi M, Faramarzi S, et al. A form of the metabolic syndrome associated with mutations in DYRK1B. N Engl J Med. 2014;370:1909\u201319.","journal-title":"N Engl J Med"},{"key":"1036_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nature13425","volume":"512","author":"I Moltke","year":"2014","unstructured":"Moltke I, Grarup N, J\u00f8rgensen ME, Bjerregaard P, Treebak JT, Fumagalli M, et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature. 2014;512:190\u20133.","journal-title":"Nature"},{"key":"1036_CR30","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1315496","volume":"370","author":"JS Albert","year":"2014","unstructured":"Albert JS, Yerges-Armstrong LM, Horenstein RB, Pollin TI, Sreenivasan UT, Chai S, et al. Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. New Engl J Med. 2014;370:2307\u201315.","journal-title":"New Engl J Med"},{"key":"1036_CR31","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s00125-021-05415-5","volume":"64","author":"TM Batista","year":"2021","unstructured":"Batista TM, Haider N, Kahn CR. Defining the underlying defect in insulin action in type 2 diabetes. Diabetologia. 2021;64:994\u20131006.","journal-title":"Diabetologia."},{"key":"1036_CR32","unstructured":"Gloudemans M, Liu B, Balliu B. gwas-download. GitHub. https:\/\/github.com\/mikegloudemans\/gwas-download. (2022)"},{"key":"1036_CR33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bioinformatics\/btv546","volume":"32","author":"T Berisa","year":"2016","unstructured":"Berisa T, Pickrell JK. Approximately independent linkage disequilibrium blocks in human populations. Bioinformatics. 2016;32:283\u20135.","journal-title":"Bioinformatics."},{"key":"1036_CR34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41588-019-0404-0","volume":"51","author":"B Liu","year":"2019","unstructured":"Liu B, Gloudemans MJ, Rao AS, Ingelsson E, Montgomery SB. Abundant associations with gene expression complicate GWAS follow-up. Nat Genet. 2019;51:768\u20139.","journal-title":"Nat Genet"},{"key":"1036_CR35","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ajhg.2016.10.003","volume":"99","author":"F Hormozdiari","year":"2016","unstructured":"Hormozdiari F, van de Bunt M, Segr\u00e8 AV, Li X, Joo JWJ, Bilow M, et al. Colocalization of GWAS and eQTL signals detects target genes. Am J Hum Genet. 2016;99:1245\u201360.","journal-title":"Am J Hum Genet"},{"key":"1036_CR36","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/bioinformatics\/btw018","volume":"32","author":"C Benner","year":"2016","unstructured":"Benner C, Spencer CCA, Havulinna AS, Salomaa V, Ripatti S, Pirinen M. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics. 2016;32:1493\u2013501.","journal-title":"Bioinformatics."},{"key":"1036_CR37","unstructured":"Gloudemans M. FINEMAP colocalization pipeline. GitHub. https:\/\/github.com\/mikegloudemans\/production_coloc_pipeline. (2018)"},{"key":"1036_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature."},{"key":"1036_CR39","doi-asserted-by":"crossref","unstructured":"de Goede OM, Nachun DC, Ferraro NM, Gloudemans MJ, Rao AS, Smail C, et al. Population-scale tissue transcriptomics maps long non-coding RNAs to complex disease. Cell. 2021;184(10):2633\u201348.","DOI":"10.1016\/j.cell.2021.03.050"},{"key":"1036_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS."},{"key":"1036_CR41","doi-asserted-by":"publisher","first-page":"D793","DOI":"10.1093\/nar\/gks1055","volume":"41","author":"A Kamburov","year":"2013","unstructured":"Kamburov A, Stelzl U, Lehrach H, Herwig R. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res. 2013;41:D793\u2013800.","journal-title":"Nucleic Acids Res"},{"key":"1036_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2157-4","volume":"581","author":"X Han","year":"2020","unstructured":"Han X, Zhou Z, Fei L, Sun H, Wang R, Chen Y, et al. Construction of a human cell landscape at single-cell level. Nature. 2020;581:303\u20139.","journal-title":"Nature."},{"key":"1036_CR43","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1093\/nar\/gkq130","volume":"38","author":"JD Dougherty","year":"2010","unstructured":"Dougherty JD, Schmidt EF, Nakajima M, Heintz N. Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells. Nucleic Acids Res. 2010;38:4218\u201330.","journal-title":"Nucleic Acids Res"},{"key":"1036_CR44","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1523\/JNEUROSCI.4488-13.2014","volume":"34","author":"X Xu","year":"2014","unstructured":"Xu X, Wells AB, O\u2019Brien DR, Nehorai A, Dougherty JD. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci. 2014;34:1420\u201331.","journal-title":"J Neurosci"},{"key":"1036_CR45","first-page":"e1008491","volume":"16","author":"I Carcamo-Orive","year":"2020","unstructured":"Carcamo-Orive I, Henrion MYR, Zhu K, Beckmann ND, Cundiff P, Moein S, et al. Predictive network modeling in human induced pluripotent stem cells identifies key driver genes for insulin responsiveness. PLOS computational biology. Public Libr Sci. 2020;16:e1008491.","journal-title":"Public Libr Sci"},{"key":"1036_CR46","first-page":"184","volume":"1","author":"P Fischer-Posovszky","year":"2008","unstructured":"Fischer-Posovszky P, Newell FS, Wabitsch M, Tornqvist HE. Human SGBS cells \u2013 a unique tool for studies of human fat cell biology. OFA. 2008;1:184\u20139.","journal-title":"OFA"},{"key":"1036_CR47","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.ajhg.2021.08.014","volume":"108","author":"B Balliu","year":"2021","unstructured":"Balliu B, Carcamo-Orive I, Gloudemans MJ, Nachun DC, Durrant MG, Gazal S, et al. An integrated approach to identify environmental modulators of genetic risk factors for complex traits. Am J Hum Genet. 2021;108:1866\u201379.","journal-title":"Am J Hum Genet"},{"key":"1036_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred R, Rust J, Chang C, Breitkreutz B-J, Stark C, Willems A, et al. The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 2021;30:187\u2013200.","journal-title":"Protein Sci"},{"key":"1036_CR49","first-page":"1695","volume":"Complex Systems","author":"G Csardi","year":"2005","unstructured":"Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal. 2005;Complex Systems:1695.","journal-title":"InterJournal."},{"key":"1036_CR50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481\u20137.","journal-title":"Nat Genet"},{"key":"1036_CR51","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.metabol.2009.10.022","volume":"59","author":"C Glaser","year":"2010","unstructured":"Glaser C, Heinrich J, Koletzko B. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism. 2010;59:993\u20139.","journal-title":"Metabolism."},{"key":"1036_CR52","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nature09266","volume":"466","author":"K Musunuru","year":"2010","unstructured":"Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466:714\u20139.","journal-title":"Nature"},{"key":"1036_CR53","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ajhg.2020.10.009","volume":"107","author":"JM Torres","year":"2020","unstructured":"Torres JM, Abdalla M, Payne A, Fernandez-Tajes J, Thurner M, Nylander V, et al. A multi-omic integrative scheme characterizes tissues of action at loci associated with type 2 diabetes. Am J Hum Genet. 2020;107:1011\u201328.","journal-title":"Am J Hum Genet"},{"key":"1036_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/BJ20102012","volume":"434","author":"S Wullschleger","year":"2011","unstructured":"Wullschleger S, Wasserman DH, Gray A, Sakamoto K, Alessi DR. Role of TAPP1 and TAPP2 adaptor binding to PtdIns(3,4)P2 in regulating insulin sensitivity defined by knock-in analysis. Biochem J. 2011;434:265\u201374.","journal-title":"Biochem J"},{"key":"1036_CR55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"1036_CR56","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/dmr.5610030208","volume":"3","author":"M-R Taskinen","year":"1987","unstructured":"Taskinen M-R. Lipoprotein lipase in diabetes. Diabetes Metab Rev. 1987;3:551\u201370.","journal-title":"Diabetes Metab Rev"},{"key":"1036_CR57","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41588-018-0088-x","volume":"50","author":"KS Small","year":"2018","unstructured":"Small KS, Todor\u010devi\u0107 M, Civelek M, El-Sayed Moustafa JS, Wang X, Simon MM, et al. Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition. Nat Genet. 2018;50:572\u201380.","journal-title":"Nat Genet"},{"key":"1036_CR58","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1172\/JCI119175","volume":"99","author":"C Lambillotte","year":"1997","unstructured":"Lambillotte C, Gilon P, Henquin JC. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest. 1997;99:414\u201323.","journal-title":"J Clin Invest"},{"key":"1036_CR59","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1172\/JCI116803","volume":"92","author":"MJ Saad","year":"1993","unstructured":"Saad MJ, Folli F, Kahn JA, Kahn CR. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest. 1993;92:2065\u201372.","journal-title":"J Clin Invest"},{"key":"1036_CR60","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/ng.3855","volume":"49","author":"S Stender","year":"2017","unstructured":"Stender S, Kozlitina J, Nordestgaard BG, Tybj\u00e6rg-Hansen A, Hobbs HH, Cohen JC. Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci. Nat Genet. 2017;49:842\u20137.","journal-title":"Nat Genet"},{"key":"1036_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","volume":"93","author":"C Thauvin-Robinet","year":"2013","unstructured":"Thauvin-Robinet C, Auclair M, Duplomb L, Caron-Debarle M, Avila M, St-Onge J, et al. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet. 2013;93:141\u20139.","journal-title":"Am J Hum Genet"},{"key":"1036_CR62","doi-asserted-by":"publisher","first-page":"309","DOI":"10.18632\/oncotarget.141","volume":"1","author":"X Li","year":"2010","unstructured":"Li X, Kumar A, Zhang F, Lee C, Li Y, Tang Z, et al. VEGF-independent angiogenic pathways induced by PDGF-C. Oncotarget. 2010;1:309\u201314.","journal-title":"Oncotarget."},{"key":"1036_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2018.01.005","volume":"62","author":"E Folestad","year":"2018","unstructured":"Folestad E, Kunath A, W\u00e5gs\u00e4ter D. PDGF-C and PDGF-D signaling in vascular diseases and animal models. Mol Asp Med. 2018;62:1\u201311.","journal-title":"Mol Asp Med"},{"key":"1036_CR64","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s00125-012-2595-0","volume":"55","author":"FH Sansbury","year":"2012","unstructured":"Sansbury FH, Flanagan SE, Houghton JAL, Shuixian Shen FL, Al-Senani AMS, Habeb AM, et al. SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion. Diabetologia. 2012;55:2381\u20135.","journal-title":"Diabetologia."},{"key":"1036_CR65","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cophys.2020.07.009","volume":"17","author":"TT Fischer","year":"2020","unstructured":"Fischer TT, Ehrlich BE. Wolfram syndrome: a monogenic model for diabetes mellitus and neurodegeneration. Curr Opinion Physiol. 2020;17:115\u201323.","journal-title":"Curr Opinion Physiol"},{"key":"1036_CR66","doi-asserted-by":"crossref","unstructured":"Burkey BF, Hoglen NC, Inskeep P, Wyman M, Hughes TE, Vath JE. Preclinical efficacy and safety of the novel anti-diabetic, anti-obesity MetAP2 inhibitor, ZGN-1061. J Pharmacol Exp Ther. 2018; [cited 2021 Apr 27]; Available from: https:\/\/jpet.aspetjournals.org\/content\/early\/2018\/02\/28\/jpet.117.246272.","DOI":"10.1124\/jpet.117.246272"},{"key":"1036_CR67","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s41467-020-15291-z","volume":"11","author":"M Fathzadeh","year":"2020","unstructured":"Fathzadeh M, Li J, Rao A, Cook N, Chennamsetty I, Seldin M, et al. FAM13A affects body fat distribution and adipocyte function. Nat Commun. 2020;11:1465.","journal-title":"Nat Commun"},{"key":"1036_CR68","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.2337\/diabetes.53.10.2713","volume":"53","author":"JV Sagen","year":"2004","unstructured":"Sagen JV, R\u00e6der H, Hathout E, Shehadeh N, Gudmundsson K, B\u00e6vre H, et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes. 2004;53:2713\u20138.","journal-title":"Diabetes"},{"key":"1036_CR69","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/CIRCRESAHA.119.315246","volume":"126","author":"Z Chen","year":"2020","unstructured":"Chen Z, Yu H, Shi X, Warren CR, Lotta LA, Friesen M, et al. Functional screening of candidate causal genes for insulin resistance in human preadipocytes and adipocytes. Circ Res. 2020;126:330\u201346.","journal-title":"Circ Res"},{"key":"1036_CR70","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.brainresrev.2004.02.003","volume":"45","author":"K Hashimoto","year":"2004","unstructured":"Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Rev. 2004;45:104\u201314.","journal-title":"Brain Res Rev"},{"key":"1036_CR71","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ajmg.b.30090","volume":"132B","author":"S Friedel","year":"2005","unstructured":"Friedel S, Horro FF, Wermter AK, Geller F, Dempfle A, Reichwald K, et al. Mutation screen of the brain derived neurotrophic factor gene (BDNF): identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit\/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2005;132B:96\u20139.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1036_CR72","doi-asserted-by":"crossref","unstructured":"Nies VJM, Sancar G, Liu W, van Zutphen T, Struik D, Yu RT, et al. Fibroblast growth factor signaling in metabolic regulation. Front Endocrinol. 2016;6 [cited 2021 Apr 22]. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2015.00193\/full.","DOI":"10.3389\/fendo.2015.00193"},{"key":"1036_CR73","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41467-018-03621-1","volume":"9","author":"AN Barbeira","year":"2018","unstructured":"Barbeira AN, Dickinson SP, Bonazzola R, Zheng J, Wheeler HE, Torres JM, et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018;9:1825.","journal-title":"Nat Commun"},{"key":"1036_CR74","unstructured":"Gloudemans M. Insulin resistance colocalization analysis. GitHub. https:\/\/github.com\/mikegloudemans\/insulin-resistance-colocalization. (2021)"},{"key":"1036_CR75","unstructured":"Gloudemans MJ, Balliu B, Nachun D, Durrant MG, Ingelsson E, Wabitsch M, et al. Cross-tissue, cross-trait post-colocalization heatmaps of candidate insulin resistance loci across the genome. Zenodo. https:\/\/zenodo.org\/record\/4659095. (2021)"},{"key":"1036_CR76","unstructured":"Gloudemans M. Cerberus: a post-colocalization toolkit. GitHub. https:\/\/github.com\/mikegloudemans\/post-coloc-toolkit. (2021)"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-022-01036-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T21:30:17Z","timestamp":1700343017000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-022-01036-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1036"],"URL":"https:\/\/doi.org\/10.1186\/s13073-022-01036-8","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SBM is a consultant for BioMarin, Myome, and Tenaya Therapeutics. EI is currently an employee at GlaxoSmithKline, but this work was done while he was still employed at Stanford University. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}